Aug 11, 2026 04:52PM
Aug 10, 2026 09:10AM
Aug 6, 2024 04:05PM
Jul 31, 2024 09:01AM
Jul 31, 2024 09:00AM
Nov 30, 2022 02:54PM
Jun 29, 2022 11:04AM Lilly to Supply an Additional 150,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide COVID-19 Treatment Options
Feb 14, 2022 05:43AM
Feb 11, 2022 03:37PM
Feb 11, 2022 03:37PM
Feb 11, 2022 03:37PM
Feb 11, 2022 05:31AM
Feb 10, 2022 07:40PM
Dec 3, 2021 04:05PM AbCellera (ABCL) -Discovered Bamlanivimab Together with Etesevimab Authorized as the First and Only Antibody Therapy for Emergency Use in COVID-19 Patients Under the Age of 12
Dec 3, 2021 04:05PM
Nov 9, 2021 04:05PM
Nov 2, 2021 04:04PM
Sep 21, 2021 01:56PM
Sep 21, 2021 01:55PM
Sep 20, 2021 07:10AM
Sep 17, 2021 09:28AM Pre-Open Stock Movers 09/17: (CRVS) (ABCL) (BGNE) Higher; (PTGX) (GRTS) (X) Lower (more...)
Sep 16, 2021 05:56PM
Sep 16, 2021 04:42PM
Sep 16, 2021 04:19PM
Sep 16, 2021 04:15PM
Aug 18, 2021 09:00AM
Jun 22, 2021 09:02AM
Jun 22, 2021 09:00AM AbCellera Continues Expansion and Strengthens Future Pandemic Preparedness with First-of- its-Kind GMP Manufacturing Facility for Therapeutic Antibodies in Canada
May 14, 2021 09:30AM
May 4, 2021 06:30AM
Apr 5, 2021 02:01PM
Apr 5, 2021 02:00PM
Mar 30, 2021 09:21AM
Mar 10, 2021 11:22AM
Mar 10, 2021 11:21AM AbCellera-Discovered Bamlanivimab Together with Etesevimab Reduced Hospitalizations and Prevented Death in Phase 3 Trial for Early COVID-19
Mar 5, 2021 03:33PM
Mar 5, 2021 03:30PM
Feb 11, 2021 04:05PM
Feb 9, 2021 08:26PM
Jan 27, 2021 07:26AM
Jan 27, 2021 07:22AM
Jan 26, 2021 07:10AM AbCellera (ABCL) -Discovered Antibody, Bamlanivimab, Administered with Etesevimab Reduced Risk of COVID-19 Hospitalizations and Death by 70%
Jan 26, 2021 07:09AM
Jan 21, 2021 08:28AM
Jan 21, 2021 08:27AM
Dec 21, 2020 09:03AM
Dec 21, 2020 09:00AM

329,957 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All